home / stock / prph / prph news

PRPH News and Press, ProPhase Labs Inc. From 09/23/25

Stock Information
Company Name: ProPhase Labs Inc.
Stock Symbol: PRPH
Market: NASDAQ
Website: prophaselabs.com
Menu
Get PRPH Alerts

News, Short Squeeze, Breakout and More Instantly...
PRPH - PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT STEP FOR CROWN MEDICAL COLLECTIONS $50 MILLION A/R INITIATIVE

COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, anno...
PRPH - ProPhase Continues its Exploration of a Crypto Treasury Strategy 

UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that the Company entered into an agreement relating to potential advisory ...

PRPH - ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor

ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, today a...

PRPH - ProPhase Labs Inc. to Participate in Renmark's Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025

Company cancels the Equity Line of Credit (ELOC) UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they w...
PRPH - Biotech Stocks Rally as Oncology Market Targets $866B by 2034

Biotech Stocks Rally as Oncology Market Targets $866B by 2034 Canada NewsWire Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC , Aug. 14, 2025 /CNW/ -- Equity Insider News Commenta...

PRPH - ProPhase Labs GAAP EPS of -$0.11, revenue of $1.2M

2025-08-13 10:06:54 ET More on ProPhase Labs ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript ProPhase Labs receives extension from Nasdaq to regain compliance Seeking Alpha’s Quant Rating on ProPhase Labs Historical earnings data for ProPha...

PRPH - ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025

ProPhase Delivers Significant Operational and Financial Improvements, Advances Multiple Non-Dilutive Liquidity Initiatives, and Targets Transformational Growth Catalysts Company granted key U.S. patent on BE-Smart ™ Esophageal Adenocarcinoma Risk Assessment test (August...
PRPH - Expected US Company Earnings on Wednesday, August 13th, 2025

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

PRPH - Expected earnings - ProPhase Labs Inc.

ProPhase Labs Inc. (PRPH) is expected to report $-0.15 for Q2 2025

PRPH - US Companies Moving the Markets, Evening edition
Tue, Aug 12, 2025 as of 4:00 pm ET

A look at the top 10 most actives in the United States Tilray Brands Inc. (TLRY) rose 3.3% to $0.9505 on volume of 287,286,194 shares ProPhase Labs Inc. (PRPH) rose 25.7% to $0.354 on volume of 271,355,529 shares BigBear.ai Inc. (BBAI) fell 15.8% to $5.97 on volume of 236,791,375 shares 1...
Previous 10 Next 10